Oslo: Antiviral drugs can help protect the function of insulin-producing cells in children newly diagnosed with type 1 diabetes, a new study has found.

Type 1 diabetes is usually diagnosed in childhood and has no cure. In this condition, these cells, which are the beta cells of the leaf, usually stop working and die.

The body of people with this condition attacks their own beta cells and damages their ability to produce insulin, leaving sufferers dependent on insulin for life.

Scientists from Oslo University Hospital in Norway said the findings suggest that low-level persistent viral infection may be linked to the condition and that type 1 diabetes could be prevented by developing new vaccines.

The research opens the door to further research into the ideal antiviral (which alone would protect the insulin-producing beta cells), the scientists added.

Study leader Dr. Ida Maria Minarek and principal investigator Prof. Knut Dahl Jørgensen and colleagues said in the study that the results of the study provide information for the discovery of antiviral drugs that can improve insulin production at the diagnosis of type 1 diabetes. Can save beta cells.

They added that more studies should be done early in the course of the disease to see if antiviral treatment can delay the process of beta-cell damage.